Effects of acupuncture and Chinese herbal medicine on quality of life and inflammatory markers in asthmatic patients: a pilot study
DOI:
https://doi.org/10.33233/fb.v24i2.4771Keywords:
acupuncture; asthma; complementary therapiesAbstract
Aim: To verify the effects of acupuncture and Chinese herbal medicine on the quality of life and inflammatory markers of asthmatic patients, recording possible adverse effects during treatment. Design: 30 individuals were randomly allocated in 3 groups: control, acupuncture and Chinese herbal medicine sham (Placebo) and Chinese acupuncture and herbal medicine intervention. Methods: The individuals received 04 sessions of equal duration with pre- and post-treatment assessment of quality of life and inflammatory markers. Medication use was also recorded. Results: A statistically significant difference was found in the quality of life questionnaire, the Vitality indicator (RSVIT) showed a p < 0.005 and the Social Aspects indicator (RSAS) showed a p < 0.004, compared to the pre-moment (p < 0.05 ) in the control, sham and intervention groups; Emotional Aspects (RSEM) with p < 0.003 and Mental Health (RSSM) with p < 0.01 obtained statistical difference only in the Sham and Intervention groups. Two-way ANOVA of repeated measures was used. The others showed no differences and there were no adverse effects. Conclusion: Chinese acupuncture and herbal medicine are safe interventions, but they only have an effect on quality of life over 4 weeks. Further studies are needed on verifying the effect on inflammatory markers and the evaluation of the intervention time.
References
Borish L. The immunology of asthma. Annals of Allergy, Asthma & Immunology. 2016;117(2):108-14. doi: 10.1016/j.anai.2016.04.022
Ministério da Saúde (BR). Estatísticas de saúde e mortalidade. Brasília: Ministério da Saúde; 2005.
Chong Neto HJ, Rosário NA, Solé D. Asthma and rhinitis in South America: how different they are from other parts of the world. Allergy, Asthma and Immunology Research [Internet]. 2012;4(2):62-7. doi: 10.4168/aair.2012.4.2.62
Cardoso TDA, Roncada C, Silva ER, Pinto LA, Jones MH, Stein RT, et al. The impact of asthma in Brazil: a longitudinal analysis of data from a Brazilian national database system. J Bras Pneumol. 2017;43(3):163-8. doi: 10.1590/s1806-37562016000000352
Roncada C, Oliveira SG, Cidade SF, Sarria EE, Mattiello R, Ojeda BS, et al. Burden of asthma among inner-city children from Southern Brazil. J Asthma. 2016;53(5):498-504. doi: 10.3109/02770903.2015.1108438
Ministério da Saúde (BR). Política Nacional de Práticas Integrativas e Complementares, 2006. Brasília: Ministério da Saúde; 2006.
World Health Organization. Acupuncture: review and analysis of reports on controlled clinical trials. Genebra: World Health Organization; 2002.
Jiang C, Jiang L, Qin Q. Conventional treatments plus acupuncture for asthma in adults and adolescent: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2019;2019(9580670):1-10. doi: 10.1155/2019/9580670
Jirui C, Wang N. Casos clínicos de acupuntura da China. São Paulo: Roca; 2007.
McCarney RW, Brinkhaus B, Lasserson TJ, Linde K. Acupuncture for chronic asthma. Cochrane Database of Systematic Reviews. 2003;1-39. doi: 10.1002/14651858.cd000008.pub2
Zhang Y, Chang J, Chi H, Mao B, Tang W, Wang L, Huang S, et al. Randomized controlled trial on treatment of bronchial asthma of qi-deficiency cold syndrome type by Pingchuan Yiqi Granule. Chin J Integr Med. 2007;13(1):27-32. doi: 10.1007/s11655-007-0027-7
Hozhang HP, Wang L, Wang Z, Xu XR, Zhou XM, Liu G, et al. Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial. Respir Med. 2018;140:42-9. doi: 10.1016/j.rmed.2018.05.014
Wang X, Tian Z, Gao F, Zhang X, Liu J, Zhuying Li, et al. Traditional Chinese medicine as an adjunctive therapy to oral montelukast for treating patients with chronic asthma. Medicine [Internet]. 2017;96(51):1-4. doi: 10.1097/md.0000000000009291
Li Z, Tian C, Wang X, Liu Y. Effectiveness of Chinese herbal medicine Ping Chuan Ke Li for the management of mild/moderate persistent asthma. Medicine. 2018;97(45):1-4. doi: 10.1097/md.0000000000012829
Pieper KK, Patil SP, Busse P, Yang N, Sampson H, Li X, et al. Safety and Tolerability of an Antiasthma Herbal Formula (ASHMI™) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation Phase I study. J Altern Complement Med. 2009;15(7):735-43. doi: 10.1089/acm.2008.0543
Wen M, Wei C, Hu Z, Srivastava K, Ko J, Xi S, et al. Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol. 2005;116(3):517-24.
Figueiredo W. Assistência à saúde dos homens: um desafio para os serviços de atenção primária. Ciênc Saúde Coletiva. 2005;10(1):105-9. doi: 10.1590/S1413-81232005000100017
Published
Issue
Section
License
Copyright (c) 2023 Carlos Eduardo Duarte Moraes, Graziele Silveira Fardin, Camila Zanini, Igor Martins da Silva, Luiza Melo Medina, Gilson Pires Dornelles, Joane Severo Ribeiro, Reginaldo de Carvalho Silva Filho, Alessandra Peres
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are authorized for non-exclusive distribution of the version of the work published in this journal (eg, publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
